ArticleNature communications2022

Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation site.

Daniel Stadlbauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.